"[These results] show that white matter lesions across all MS patients tend to injure the white matter depression network, which may create a vulnerability for depression in the MS population as a ...

Healthcare providers use continuous MRI scans performed over the course of a patient's life to monitor the progression of multiple sclerosis, where the immune system attacks the protective myelin ...

Collaborating scientists at the Karolinska Institute and at Stockholm University used a technology called in situ sequencing (ISS) to help reveal at the cellular level how lesions in multiple ...

Prospective tracking of "smoldering" chronic active lesions with notable darkened rims in people with multiple sclerosis (MS), previously only detectable upon autopsy, suggests the lesions are linked ...

Paramagnetic rim lesions may help assess MS risk in people with radiologically isolated syndrome before symptoms appear.

Advanced MRI techniques can differentiate between degenerative and reparative processes in MS lesions, offering insights into disease progression. Quantitative MRI (qMRI) provides detailed biophysical ...

Honolulu, HI - A new study shows that in patients with relapsing-remitting multiple sclerosis (MS), daily treatment with 80 mg of simvastatin significantly decreased the number and volume of active MS ...

Between 30 to 50 percent of people living with multiple sclerosis (MS) will experience memory problems but the cause is uncertain. Brain lesions are the hallmark imaging sign used to diagnose MS and ...

Immunic Inc (NASDAQ:IMUX)’s chief medical officer Dr Andreas Muehler talked with Proactive about new data presented at the ACTRIMS Forum in San Diego, highlighting findings from the company’s phase 2 ...

Lesion-induced network disconnection is a stronger predictor of cognitive outcomes in MS than lesion burden alone. Disconnectome mapping provides a comprehensive understanding of how structural damage ...

Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led ...

Just before Christmas several years ago, Dr. Claudia Lucchinetti befriended one of her patients. The woman, a young mother, had been presented to the Mayo Clinic neurologist with an unusual case of ...